Latest revenue
$2.90B
as of 2026-03-31
Latest net income
$252.0M
as of 2026-03-31
Net margin
8.7%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $21.61B
- Enterprise value
- $27.68B
- P/E (trailing)
- 21.8×
- Forward P/E
- —
- P/B
- 2.93×
- Dividend yield
- 1.7%
- 52-wk high
- $213.50
- 52-wk low
- $164.65
- Beta
- —
- Shares out
- 110.7M
5-year trend
About DGX
Business description and risk factors will appear here once DGX's latest filing is fully ingested.
Profitability
Operating margin
14.1%
3.4%Net margin
9.0%
1.9%Return on equity
13.8%
7.7%Return on assets
6.1%
13.4%Leverage
Debt / equity
1.26×
8.7%Long-term debt / equity
0.72×
13.0%Debt / assets
55.8%
3.8%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $2.90B | +9.2% | $252.0M | +14.5% | 8.7% |
Q4 2025 2025-12-31 | $2.81B | +7.1% | $245.0M | +10.4% | 8.7% |
Q3 2025 2025-09-30 | $2.82B | +13.2% | $245.0M | +8.4% | 8.7% |
Q2 2025 2025-06-30 | $2.76B | +15.2% | $282.0M | +23.1% | 10.2% |
Q1 2025 2025-03-31 | $2.65B | +12.1% | $220.0M | +13.4% | 8.3% |
Q4 2024 2024-12-31 | $2.62B | — | $222.0M | — | 8.5% |
Q3 2024 2024-09-30 | $2.49B | +8.4% | $226.0M | +0.4% | 9.1% |
Q2 2024 2024-06-30 | $2.40B | +2.5% | $229.0M | -2.6% | 9.6% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Medical Laboratories · SIC 8071
Your notes
Keep private notes on DGX — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$35.0M
Net activity
−$35.0M
Distinct insiders
8
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns DGX
No institutional holdings on file for DGX yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once DGX's latest filing finishes processing.